Notably, ESR1 gene mutations, which encode ERα, are rare in primary breast cancer but occur in about 20% of patients with metastatic breast cancer (MBC) who have undergone endocrine therapy [146–148]. The gene discussed is ESR1; the disease is breast cancer.